PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

45,809 stories, page 650 of 764

Advanced search
🌍Researchdoi.orgTier 1 · Research record

Dynamic Condylar Screw Versus Long PFN in Subtrochanteric Fractures

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

AI‐Based Functional Outcome Comparison of Nails in Unstable Intertrochanteric Femur Fracture

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Alpha‐Blockers in Cervical Radiculopathy

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Fracture Healing After Cephalomedullary Nailing with Zoledronic Acid

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Rigid Versus Hybrid Fixation in Both‐Bone Forearm Fractures

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Designing Nanobots for Targeted Drug Delivery and the Application of Nanotechnology in Modern Medical Advancements

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

AI‐Driven Drug Discovery and Personalized Medicine in Cancer

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Heterocyclic Compound Having Herbicides Activity

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Heterocyclic Compounds as Anticonvulsants, Antipyretics, Antiallergic Agents, and Antileprosy Agents

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Heterocyclic Compounds as Anti‐Inflammatory Agents

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Heterocyclic Compounds as Anticancer Agents

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Heterocyclic Compounds as Antimicrobial (Antibacterial, Antifungal, Antiviral, and Anthelmintics) Agent

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Synthesis and Biological Evaluation of Thiophene‐ and Piperazine‐Based Active Compounds

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Heterocyclic Compounds as Antihypertensive Agents

CrossrefOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of OWC PHARMACEUTICAL RESEARCH CORP – OTC:OWCP

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Ultragenyx Pharmaceutical Inc. – NASDAQ:RARE

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SITC Leaders Ring the NYSE Opening Bell to Commemorate the Annual Biotech Strategic Meeting

OncodailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Anhui Sunhere Pharmaceutical Excipients Co., Ltd. Class A Actuals & Estimates (SZSE:300452)

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

LX2006 Gene Therapy: FDA-Supported Accelerated Approval Pathway and Positive Interim Outcomes in Friedreich Ataxia Cardiomyopathy

Vera HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Ok Biotech Co., Ltd. – TWSE:4155

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

TAK-755 from Takeda Pharmaceutical Co. - enzyme replacement for a rare bleeding disorder

Ad-hoc-news.deOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Wall Street says Johnson and Johnson’s FDA-approved psoriasis drug should create 'significant value' for Protagonist Therapeutics

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of RTW Biotech Opportunities Ltd USD – AQUISUK:RTWL

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of ENLIE Pharmaceutical JSC – UPCOM:BCP

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Kobayashi Pharmaceutical Co., Ltd. – MUN:KOY

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of ASKA Pharmaceutical Holdings Co., Ltd. – TSE:4886

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of ASKA Pharmaceutical Holdings Co., Ltd. – TSE:4886

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

We Don't Call It Medicine Until It's Proven Safe

ACCESS NewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What To Expect At DEA Rescheduling Hearing: When Does Marijuana Become Medicine? The Answer Is Proof

Newswire.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Fermenta Biotech Ltd – NSE:FERMENTA

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What to Know About This $345,000 Enliven Insider Sale as the Stock Soars 130%

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Fermenta Biotech Ltd – NSE:FERMENTA

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of ENLIE Pharmaceutical JSC – UPCOM:BCP

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Towa Pharmaceutical Co., Ltd. – DUS:6QC

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Shandong Pharmaceutical Glass Co., Ltd. Class A – SSE:600529

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Veraxa Biotech AG – NASDAQ:VRXAW

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What to Know About OrbiMed's $39 Million Enliven Therapeutics Stock Sale Amid a 130% Rally

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of OWC PHARMACEUTICAL RESEARCH CORP – OTC:OWCP

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages

Ophthalmology TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

2 Biotech Stocks Worth Buying Before Their Potential Buyouts

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of HeiLongJiang ZBD Pharmaceutical Co., Ltd. Class A – SSE:603567

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

2 Biotech Stocks Worth Buying Before Their Potential Buyouts

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Opioid use disorder: Kratom remains unapproved with signals of serious toxicity and dependence

Vera HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nvidia invests in Generate Biomedicines, targeting $1.8T market with AI-driven drug discovery

BitgetOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Generate Biomedicines stock ends week back above IPO price as volume jumps

TechStock²Original source
🌍discoverynews.google.comTier 3 · Aggregated media

From milk to fruits, FDA finds expired items worth over ₹2.35 lakh in warehouses

The HinduOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease

Dermatology TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

U.S. FDA Accepts sNDA for Roflumilast Cream for PsO in Young Kids; PDUFA Date Set for June 29, 2026.

The Dermatology DigestOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US, Texas biotech firm to build 'Noah's Ark' for endangered species

YahooOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nvidia Owns This Under-the-Radar $20 Stock Poised to Disrupt a $1.8 Trillion Market

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nvidia invests in Generate Biomedicines, targeting $1.8T market with AI-driven drug discovery

Crypto BriefingOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eli Lilly (LLY) Announces Positive Phase 3 Results for Jaypirca Combination in Relapsed CLL/SLL

Insider MonkeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eli Lilly (LLY) Announces Positive Phase 3 Results for Jaypirca Combination in Relapsed CLL/SLL

Insider MonkeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eli Lilly (LLY) Announces Positive Phase 3 Results for Jaypirca Combination in Relapsed CLL/SLL

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Union Bancaire Privee UBP SA Sells 44,839 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Ltd. $TEVA Shares Sold by Sterling Capital Management LLC

MarketBeatOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Pfizer’s Seagen bet sours further; China debate continues to heat up; and more

Endpoints NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Depo-Provera: Risks, FDA Warnings and Legal Concerns

Drugwatch.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Cracks Down On Illegal Gutkha & Adulterated Food In Pune; 198 Raids, ₹84 Lakh Worth Of Gutkha Seized, 92

Free Press JournalOriginal source